Cubist Systematic Strategies LLC Increases Position in Senseonics Holdings, Inc. (NYSE:SENS)

Cubist Systematic Strategies LLC raised its holdings in shares of Senseonics Holdings, Inc. (NYSE:SENS) by 25.9% in the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 415,404 shares of the company’s stock after buying an additional 85,501 shares during the period. Cubist Systematic Strategies LLC’s holdings in Senseonics were worth $166,000 at the end of the most recent reporting period.

Several other large investors have also modified their holdings of the business. State Board of Administration of Florida Retirement System purchased a new stake in shares of Senseonics in the first quarter valued at approximately $91,000. Virtu Financial LLC purchased a new stake in Senseonics during the first quarter worth $162,000. Price T Rowe Associates Inc. MD lifted its holdings in Senseonics by 16.1% during the first quarter. Price T Rowe Associates Inc. MD now owns 367,200 shares of the company’s stock worth $196,000 after buying an additional 51,000 shares during the period. Mirae Asset Global Investments Co. Ltd. lifted its holdings in Senseonics by 30.2% during the first quarter. Mirae Asset Global Investments Co. Ltd. now owns 909,931 shares of the company’s stock worth $483,000 after buying an additional 211,128 shares during the period. Finally, Vanguard Group Inc. lifted its holdings in Senseonics by 0.7% during the first quarter. Vanguard Group Inc. now owns 22,525,039 shares of the company’s stock worth $11,963,000 after buying an additional 155,715 shares during the period. Hedge funds and other institutional investors own 12.36% of the company’s stock.

Analyst Ratings Changes

A number of analysts have weighed in on the company. StockNews.com assumed coverage on Senseonics in a report on Tuesday. They set a “sell” rating for the company. HC Wainwright restated a “buy” rating and set a $2.00 target price on shares of Senseonics in a report on Wednesday, August 14th.

Senseonics Price Performance

NYSE:SENS opened at $0.36 on Tuesday. Senseonics Holdings, Inc. has a one year low of $0.32 and a one year high of $0.75. The company has a debt-to-equity ratio of 59.17, a quick ratio of 2.89 and a current ratio of 3.11. The firm has a market cap of $192.39 million, a price-to-earnings ratio of -2.59 and a beta of 0.79. The firm’s fifty day moving average is $0.38 and its two-hundred day moving average is $0.42.

Senseonics (NYSE:SENS) last posted its quarterly earnings results on Thursday, August 8th. The company reported ($0.03) EPS for the quarter, meeting the consensus estimate of ($0.03). Senseonics had a negative net margin of 335.15% and a negative return on equity of 299.69%. The company had revenue of $4.87 million for the quarter, compared to analyst estimates of $4.86 million. Research analysts expect that Senseonics Holdings, Inc. will post -0.13 EPS for the current year.

Senseonics Company Profile

Senseonics Holdings, Inc, a medical technology company, focuses on development and manufacturing of continuous glucose monitoring (CGM) systems for people with diabetes in the United States and internationally. The company's products include Eversense, Eversense XL, and Eversense E3 that are implantable CGM systems to measure glucose levels in people with diabetes through an under-the-skin sensor, a removable and rechargeable smart transmitter, and a convenient app for real-time diabetes monitoring and management.